Search
Search Results
##search.searchResults.foundPlural##
-
FUNGAL INFECTIONS OF THE EAR IN IMMUNOCOMPROMISED HOST: A REVIEW
3583PDF: 1370HTML: 3738Letter to Editor: 187 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3305PDF: 1344HTML: 2655 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1422PDF: 904Suppl. Files: 455HTML: 237 -
DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE
277660PDF: 1792HTML: 3870 -
-
Evaluating the use of meropenem in hematologic patients with febrile neutropenia A retrospective observational single-cohort study
991PDF: 455HTML: 135 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1624PDF: 798HTML: 862jdoe, table 2 infections CML .doc: 194jdoe, table 1 infections CML .doc: 181 -
TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL
6972PDF: 3921HTML: 24881 -
DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE
3679PDF: 1285HTML: 729Figure 2: 452Figure 1: 3117 -
-
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
1945PDF: 1166HTML: 267 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1463PDF: 1062HTML: 217 -
Severe immune thrombocytopenia (ITP) following SARS-CoV-2 mRNA vaccine in a girl on immunosuppressive treatment and in prolonged stable phase of ITP. immune thrombocytopenia following mRNA vaccine
2120PDF: 568HTML: 1144 -
Tenofovir as Rescue Therapy Following Clinical Failure to Lamivudine in Severe Acute Hepatitis B
2117PDF: 820HTML: 1640Figure 1: 317 -
ASSESSMENT OF THE EFFICACY OF PROCALCITONIN, C-REACTIVE PROTEIN AND ALBUMIN LEVELS-GUIDED ANTIBIOTICS USE IN SEPSIS
937PDF: 504Html: 143Suppl. Files: 173 -
THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association
1060PDF: 1061HTML: 97 -
How I treat acute and persistent sickle cell pain
1929PDF: 1117HTML: 485 -
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3239PDF: 1335HTML: 4131 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3547PDF: 1493HTML: 4398CoverLetter: 184Figure1: 194 -
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
1371PDF: 758HTML: 942 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1385PDF: 1308HTML: 100 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
974PDF: 534HTML: 722







